Our Professor of Practice now in new role

Source: https://bsse.ethz.ch/news-and-events/d-bsse-news/2024/09/our-professor-of-practice-now-in-new-role.html Parent: https://bsse.ethz.ch/news-and-events/d-bsse-news.html?AUTHOR=Q2Fyb2xpbiBBcm5kdCBGb3BwYQ&path=L2NvbnRlbnQvc3BlY2lhbGludGVyZXN0L2Jzc2UvZGVwYXJ0bWVudC9lbi9uZXdzLWFuZC1ldmVudHMvamNyOmNvbnRlbnQvcGFyL25ld3NmZWVkXzQzMTg

Sylke Poehling, first Professor of Practice at D-BSSE, Senior Vice President for Therapeutic Modalities at Roche Pharma Research & Early Development (pRED), becomes the Chief Executive Officer of Spark Therapeutics, a Philadelphia-based company specialised in developing gene therapies. Spark is a member of the Roche group. Congratulations, Sylke!